A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Regorafenib
Related studies linked through entity extraction aliases.
Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib
- Status
- COMPLETED
- Phase
- PHASE2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study of Perindopril and Regorafenib in mCRC
- Status
- COMPLETED
- Phase
- PHASE2
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Ginseng for Patients on Regorafenib
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Regorafenib and Sildenafil for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Regorafenib in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)
- Status
- COMPLETED
- Phase
- PHASE2
Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2